Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD11B1 | P28845 | 2/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | CRHBP | P24387 | 1/20 | 0.33 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16410853 | 0.80 | C3AR1 (0.36) | — | |
| SCHEMBL16410755 | 0.77 | ACAT2 (0.43) | KDM4EMAPTNPC1GAAMAPK1 | |
| SCHEMBL16410726 | 0.75 | ALDH1A1 (0.32) | KDM4EMAPTNPC1GAAMAPK1 | |
| SCHEMBL16410620 | 0.70 | ACAT2 (0.36) | KDM4EMAPTNPC1GAAMAPK1 | |
| SCHEMBL16410766 | 0.69 | ACAT2 (0.47) | — | |
| SCHEMBL16410667 | 0.69 | ACAT2 (0.38) | KDM4EMAPTNPC1GAAMAPK1 | |
| SCHEMBL16410802 | 0.68 | ADCY8 (0.31) | — | |
| SCHEMBL16410816 | 0.67 | ACAT2 (0.45) | — | |
| SCHEMBL16410847 | 0.64 | ACAT2 (0.37) | — | |
| SCHEMBL15506263 | 0.59 | ALDH1A1 (0.52) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2015007730-A1 | SPIROQUINOXALINE DERIVATIVES AS INHIBITORS OF NON-APOPTOTIC REGULATED CELL-DEATH | Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) (DE) | 2015-01-22 | — | — | WO | disclosed |